Skip to content
Toggle main navigation
PURPOSE logo
PURPOSE logo
  • Home
  • Events
  • Opportunities
  • News & Publications
  • T90/R90 HEAL Pain Cohort Program
  • Mobile App
  • About
  • Affiliate Networks
    • Music4Pain (U24)
    • ENSEMBLE Network (U24)
    • US Association for the Study of Pain (USASP)
    • Pain Research Forum (PRF)
    • ForceNET (U24)
    • NeuronS_MATTR (U24)
    • SPINEWORK Network (U24)
MoreOpen dropdown to see remaining menu items
    Log in
    Request to Join
    Contact
    Neurovations Education
    [email protected]

    United States

    [email protected]
    707-260-0848
    Links
    NIH HEAL Initiative
    Research in Pain Management

    News & Publications

    Do you have news or publications to share with the PURPOSE Network? Submit your news below.

    Submit Your News or Publication
    All
    Acquired Cognitive Impairment
    Acupuncture
    Addiction
    Ageing
    Alcohol Use / Alcohol Use Disorder (AUD)
    Analgesics
    Analgesics, Topical
    Anatomy
    Anesthesia, General
    Anesthesia, Local
    Anesthesia, Spinal
    Animal Models
    Anxiety
    Arthritis, Rheumatoid
    Artificial Intelligence
    See all

    Highlighted News

    Results (2561)

    Newest
    Clinical and Patient-Reported Outcomes Following Multidisciplinary Management of Cancer-Related Pain: Protocol for a Prospective Observational Pre-Post Study

    Clinical and Patient-Reported Outcomes Following Multidisciplinary Management of Cancer-Related Pain: Protocol for a Prospective Observational Pre-Post Study

    JMIR Res Protoc. 2026 Aug 27;15:e92566. doi: 10.2196/92566.ABSTRACTBACKGROUND: Cancer-related pain remains highly prevalent and frequently undertreated despite advances in oncological therapies and analgesic strategies. Multidisciplinary approaches are recommended to optimize complex cancer pain management and integrate supportive care; however, robust real-world evidence evaluating their measurab
    August 28, 2026
    Submitting Applications with International Collaborations

    Submitting Applications with International Collaborations

    In 2025, we announced an updated NIH Policy on Foreign Subawards (NOT-OD-25-104) and introduced the Collaborative International Research application and award structure using the PF5 activity code (NOT-OD-25-155) which was implemented earlier this year.  The multi-project PF5 structure accommodates individual components for international projects which, if selected for funding, become separate dir
    August 27, 2026
    When Are Two Heads Better Than One? Considerations When Using the NIH Multiple Principal Investigator Model

    When Are Two Heads Better Than One? Considerations When Using the NIH Multiple Principal Investigator Model

    Nearly two decades ago, we began allowing more than one researcher to be designated as program director/principal investigator (PD/PI) on a single grant award. The multiple PD/PI (MPI) model can provide important benefits, including giving each investigator credit as an NIH-designated PD/PI, but it is not required to conduct collaborative or team science. It is intended to supplement—not replace—t
    August 27, 2026
    Notice of Informational Webinar on PAR-27-054 "Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)"

    Notice of Informational Webinar on PAR-27-054 "Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)"

    Notice NOT-GM-26-020 from the NIH Guide for Grants and Contracts
    August 27, 2026
    Notice of Informational Webinar on the NIGMS Small Business Program

    Notice of Informational Webinar on the NIGMS Small Business Program

    Notice NOT-GM-26-014 from the NIH Guide for Grants and Contracts
    August 27, 2026
    Notice of Informational Webinar on PAR-27-056 "Limited Competition: Institutional Development Award (IDeA) for Clinical  and  Translational Research (CTR) (P30 - CT Optional)"

    Notice of Informational Webinar on PAR-27-056 "Limited Competition: Institutional Development Award (IDeA) for Clinical and Translational Research (CTR) (P30 - CT Optional)"

    Notice NOT-GM-26-013 from the NIH Guide for Grants and Contracts
    August 27, 2026
    Notice of Correction to Reference Letters Due Date in PAR-27-026, "Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)"

    Notice of Correction to Reference Letters Due Date in PAR-27-026, "Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)"

    Notice NOT-DA-26-016 from the NIH Guide for Grants and Contracts
    August 27, 2026
    Request for Information: Draft NIH Policy on Sharing Summary Level Study Results with Clinical Research Participants

    Request for Information: Draft NIH Policy on Sharing Summary Level Study Results with Clinical Research Participants

    Notice NOT-OD-26-113 from the NIH Guide for Grants and Contracts
    August 27, 2026
    The Informational Blackout chronic pain and fatigue as rational outputs of a brain operating on degraded biological signals

    The Informational Blackout chronic pain and fatigue as rational outputs of a brain operating on degraded biological signals

    Front Pain Res (Lausanne). 2026 Aug 12;7:1896306. doi: 10.3389/fpain.2026.1896306. eCollection 2026.ABSTRACTChronic pain and fatigue have resisted pharmacological resolution for two decades despite detailed mechanistic characterisation of nociceptive circuits. This perspective argues that the problem is not insufficient data but a mismatch between the level at which the dominant model operates and
    August 27, 2026
    Methodological Evolution of Diffusion MRI in Chronic Pain: A Narrative Review

    Methodological Evolution of Diffusion MRI in Chronic Pain: A Narrative Review

    J Pain Res. 2026 Aug 22;19:624864. doi: 10.2147/JPR.S624864. eCollection 2026.ABSTRACTChronic pain is a highly prevalent and clinically heterogeneous condition, and its underlying mechanisms remain incompletely understood. The lack of objective, clinically validated biomarkers has hindered diagnostic stratification, mechanistic insight, and treatment evaluation. Diffusion magnetic resonance imagin
    August 27, 2026
    Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Chronic Pain

    Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Chronic Pain

    Brain Sci. 2026 Aug 21;16(8):896. doi: 10.3390/brainsci16080896.ABSTRACTChronic pain is a major global health burden and often remains difficult to treat with current therapies, which frequently provide incomplete relief and may cause systemic side effects. As essential organelles in eukaryotic cells, mitochondria facilitate ATP synthesis and serve as key regulators of calcium homeostasis and apop
    August 27, 2026
    Recent Insights on Cell-Type-Specific Lactylation Driving Neuropathic Pain Chronification

    Recent Insights on Cell-Type-Specific Lactylation Driving Neuropathic Pain Chronification

    Neurochem Int. 2026 Aug 26:106249. doi: 10.1016/j.neuint.2026.106249. Online ahead of print.ABSTRACTNeuropathic pain (NP) is a debilitating chronic condition whose molecular mechanisms remain incompletely understood, limiting the development of effective disease-modifying therapies. Lactylation, a lactate-derived post-translational modification of histone and non-histone lysine residues, has recen
    August 26, 2026
    Now Available: Exploring Pain Episode 7 – Pain Mechanisms and Treatment

    Now Available: Exploring Pain Episode 7 – Pain Mechanisms and Treatment

    New Video Available: Pain Mechanisms and TreatmentWatch the full presentation now in the Media CenterIn Episode 7 of the Exploring Pain series, host Laura Wandner, PhD, sits down with Ted Price, PhD, Director of the Center for Advanced Pain Studies at UT Dallas, to explore how molecular neuroscience is advancing precision pain medicine. Price highlights single-cell transcriptomic and proteomic fin
    August 25, 2026
    A qualitative inquiry into the environmental barriers and facilitators to non-specific low back pain clinical practice guideline adherence among Canadian physiotherapists

    A qualitative inquiry into the environmental barriers and facilitators to non-specific low back pain clinical practice guideline adherence among Canadian physiotherapists

    Physiother Theory Pract. 2026 Aug 24:1-18. doi: 10.1080/09593985.2026.2716384. Online ahead of print.ABSTRACTBACKGROUND: Nonspecific low back pain (NSLBP) has profound adverse impacts at both the individual level, such as pain and dysfunction, as well as the health system level, including high care costs. Prior research suggests that physiotherapists adhere to some aspects of NSLBP clinical practi
    August 24, 2026
    Pain Assessment and Management in Patients with Beta-Thalassemia Major: A Systematic Review

    Pain Assessment and Management in Patients with Beta-Thalassemia Major: A Systematic Review

    Hemoglobin. 2026 Aug 24:1-10. doi: 10.1080/03630269.2026.2708907. Online ahead of print.ABSTRACTIn recent years, pain has become a common and emergent complication in patients with β-thalassemia major. This systematic review investigates the assessment and management of pain in patients with β-thalassemia major. The Medline (via PubMed), Cochrane Library, and Web of Science databases were searched
    August 24, 2026
    Enhanced Pain Management With Combined EMLA Patch and Local Anesthetic Infiltration in Transradial Angiography

    Enhanced Pain Management With Combined EMLA Patch and Local Anesthetic Infiltration in Transradial Angiography

    Clin Cardiol. 2026 Aug;49(8):e70444. doi: 10.1002/clc.70444.ABSTRACTBACKGROUND/OBJECTIVES: Pain at the radial access site remains common during coronary angiography. Evidence on topical anesthesia with EMLA patches is inconsistent, and the added value of combining EMLA with local lidocaine infiltration has not been fully clarified. This study compared the analgesic effectiveness of three strategie
    August 24, 2026
    Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain

    Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain

    Cochrane Database Syst Rev. 2026 Aug 24;8:CD016383. doi: 10.1002/14651858.CD016383.ABSTRACTThis is a protocol for a Cochrane review (intervention). The objectives are as follows: To evaluate the benefits and harms of transcutaneous electrical nerve stimulation (TENS), used alone or as an adjunct to other interventions, compared with sham TENS, placebo, no treatment, or other clinical interventions
    August 24, 2026
    Subconjunctival Botulinum Toxin-A Injection as a Treatment for Neuropathic Corneal Pain

    Subconjunctival Botulinum Toxin-A Injection as a Treatment for Neuropathic Corneal Pain

    Cornea. 2026 Aug 4. doi: 10.1097/ICO.0000000000004262. Online ahead of print.ABSTRACTPURPOSE: To describe a new perilimbal subconjunctival botulinum toxin type A (BTX-A) injection technique and its outcomes in patients with refractory neuropathic corneal pain.METHODS: The procedure involves BTX-A injection into the nasal and temporal perilimbal subconjunctival spaces (10 units per site, 20 units t
    August 24, 2026
    Average pain over time, but not current pain, is associated with salivary secretory immunoglobulin a in chronic back pain: A cross-sectional study

    Average pain over time, but not current pain, is associated with salivary secretory immunoglobulin a in chronic back pain: A cross-sectional study

    Mol Pain. 2026 Jan-Dec;22:17448069261483479. doi: 10.1177/17448069261483479. Epub 2026 Aug 24.ABSTRACTChronic pain is accompanied by widespread physiological dysregulation, yet the mucosal immune system has received little attention. Salivary secretory-immunoglobulin-A (S-IgA) is a non-invasive biomarker of mucosal immunity modulated by sustained stress and autonomic activity. This cross-sectional
    August 24, 2026
    Extending the Fear-Avoidance Model of pain to youth: Psychometric evaluation of the 11-item Tampa Scale of Kinesiophobia in children and adolescents

    Extending the Fear-Avoidance Model of pain to youth: Psychometric evaluation of the 11-item Tampa Scale of Kinesiophobia in children and adolescents

    J Pain. 2026 Aug 23:106420. doi: 10.1016/j.jpain.2026.106420. Online ahead of print.ABSTRACTKinesiophobia plays a central role in understanding adult pain mechanisms, yet its assessment and theoretical relevance in pediatric pain remain poorly understood. Research to clarify the role of kinesiophobia in pediatric populations requires a valid and reliable measure of the construct. The most commonly
    August 24, 2026